Journal of Translational Medicine,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: May 23, 2022
Abstract
As
a
promising
alternative
platform
for
cellular
immunotherapy,
natural
killer
cells
(NK)
have
recently
gained
attention
as
an
important
type
of
innate
immune
regulatory
cell.
NK
can
rapidly
kill
multiple
adjacent
cancer
through
non-MHC-restrictive
effects.
Although
tumors
may
develop
resistance
mechanisms
to
endogenous
cell
attack,
in
vitro
activation,
expansion,
and
genetic
modification
greatly
enhance
their
anti-tumor
activity
give
them
the
ability
overcome
drug
resistance.
Some
these
approaches
been
translated
into
clinical
applications,
trials
infusion
patients
with
hematological
malignancies
solid
thus
far
yielded
many
encouraging
results.
CAR-T
exhibited
great
success
treating
malignancies,
but
drawbacks
include
high
manufacturing
costs
potentially
fatal
toxicity,
such
cytokine
release
syndrome.
To
issues,
CAR-NK
were
generated
engineering
demonstrated
significant
responses
lower
adverse
effects
compared
therapy.
In
this
review,
we
summarize
recent
advances
focusing
on
biology
function,
types
therapy,
future
perspectives
Nature Reviews Gastroenterology & Hepatology,
Journal Year:
2020,
Volume and Issue:
17(9), P. 557 - 588
Published: June 30, 2020
Abstract
Cholangiocarcinoma
(CCA)
includes
a
cluster
of
highly
heterogeneous
biliary
malignant
tumours
that
can
arise
at
any
point
the
tree.
Their
incidence
is
increasing
globally,
currently
accounting
for
~15%
all
primary
liver
cancers
and
~3%
gastrointestinal
malignancies.
The
silent
presentation
these
combined
with
their
aggressive
nature
refractoriness
to
chemotherapy
contribute
alarming
mortality,
representing
~2%
cancer-related
deaths
worldwide
yearly.
current
diagnosis
CCA
by
non-invasive
approaches
not
accurate
enough,
histological
confirmation
necessary.
Furthermore,
high
heterogeneity
CCAs
genomic,
epigenetic
molecular
levels
severely
compromises
efficacy
available
therapies.
In
past
decade,
efforts
have
been
made
understand
complexity
develop
new
diagnostic
tools
therapies
might
help
improve
patient
outcomes.
this
expert
Consensus
Statement,
which
endorsed
European
Network
Study
Cholangiocarcinoma,
we
aim
summarize
critically
discuss
latest
advances
in
CCA,
mostly
focusing
on
classification,
cells
origin,
genetic
abnormalities,
alterations,
biomarker
discovery
treatments.
horizon
next
decade
from
2020
onwards
highlighted.
Journal of Hematology & Oncology,
Journal Year:
2021,
Volume and Issue:
14(1)
Published: Jan. 6, 2021
Abstract
Natural
killer
(NK)
cell
is
a
specialized
immune
effector
type
that
plays
critical
role
in
activation
against
abnormal
cells.
Different
from
events
required
for
T
activation,
NK
governed
by
the
interaction
of
receptors
with
target
cells,
independent
antigen
processing
and
presentation.
Due
to
relatively
unsophisticated
cues
has
gained
significant
attention
field
cancer
immunotherapy.
Many
efforts
are
emerging
developing
engineering
cell-based
In
this
review,
we
provide
our
current
understandings
biology,
ongoing
pre-clinical
clinical
development
therapies
discuss
progress,
challenges,
future
perspectives.
The Lancet Respiratory Medicine,
Journal Year:
2021,
Volume and Issue:
9(6), P. 622 - 642
Published: May 7, 2021
The
zoonotic
SARS-CoV-2
virus
that
causes
COVID-19
continues
to
spread
worldwide,
with
devastating
consequences.
While
the
medical
community
has
gained
insight
into
epidemiology
of
COVID-19,
important
questions
remain
about
clinical
complexities
and
underlying
mechanisms
disease
phenotypes.
Severe
most
commonly
involves
respiratory
manifestations,
although
other
systems
are
also
affected,
acute
is
often
followed
by
protracted
complications.
Such
complex
manifestations
suggest
dysregulates
host
response,
triggering
wide-ranging
immuno-inflammatory,
thrombotic,
parenchymal
derangements.
We
review
intricacies
pathophysiology,
its
various
phenotypes,
anti-SARS-CoV-2
response
at
humoral
cellular
levels.
Some
similarities
exist
between
failure
origins,
but
evidence
for
many
distinctive
mechanistic
features
indicates
constitutes
a
new
entity,
emerging
data
suggesting
involvement
an
endotheliopathy-centred
pathophysiology.
Further
research,
combining
basic
studies,
needed
advance
understanding
pathophysiological
characterise
immuno-inflammatory
derangements
across
range
phenotypes
enable
optimum
care
patients
COVID-19.
Science Immunology,
Journal Year:
2020,
Volume and Issue:
5(50)
Published: Aug. 14, 2020
Understanding
innate
immune
responses
in
COVID-19
is
important
to
decipher
mechanisms
of
host
and
interpret
disease
pathogenesis.
Natural
killer
(NK)
cells
are
effector
lymphocytes
that
respond
acute
viral
infections
but
might
also
contribute
immunopathology.
Using
28-color
flow
cytometry,
we
here
reveal
strong
NK
cell
activation
across
distinct
subsets
peripheral
blood
patients.
This
pattern
was
mirrored
scRNA-seq
signatures
bronchoalveolar
lavage
from
Unsupervised
high-dimensional
analysis
furthermore
identified
immunotypes
were
linked
severity.
Hallmarks
these
high
expression
perforin,
NKG2C,
Ksp37,
reflecting
increased
presence
adaptive
circulation
patients
with
severe
disease.
Finally,
arming
CD56bright
observed
states,
driven
by
a
defined
protein-protein
interaction
network
inflammatory
soluble
factors.
study
provides
detailed
map
the
landscape
Frontiers in Immunology,
Journal Year:
2018,
Volume and Issue:
9
Published: Nov. 13, 2018
During
placentation
invasive
extravillous
trophoblasts
(EVTs)
migrate
into
the
maternal
uterus
and
modify
its
vessels.
In
particular,
remodelling
of
spiral
arteries
by
EVTs
is
critical
for
adapting
blood
flow
nutrient
transport
to
developing
fetus.
Failures
in
this
process
have
been
noticed
different
pregnancy
complications
such
as
preeclampsia,
intrauterine
growth
restriction,
stillbirth
or
recurrent
abortion.
Upon
invasion
decidua,
endometrium
pregnancy,
encounter
cell
types
decidual
macrophages,
uterine
NK
(uNK)
cells
stromal
expressing
a
plethora
factors
cytokines.
Here,
we
will
summarise
development
EVT
lineage,
occurring
independently
environment,
formation
subtypes.
Further,
discuss
interactions
with
arteries,
veins
lymphatics
illustrate
how
decidua
immune
regulate
differentiation,
survival.
The
present
literature
suggests
that
environment
soluble
critically
modulate
function
reproductive
success.
The Journal of Experimental Medicine,
Journal Year:
2019,
Volume and Issue:
216(9), P. 2113 - 2127
Published: July 3, 2019
NK
cells
eliminate
virus-infected
and
tumor
by
releasing
cytotoxic
granules
containing
granzyme
B
(GrzB)
or
engaging
death
receptors
that
initiate
caspase
cascades.
The
orchestrated
interplay
between
both
cell
pathways
remains
poorly
defined.
Here
we
simultaneously
measure
the
activities
of
GrzB
caspase-8
in
upon
contact
with
human
cells.
We
observed
switch
from
inducing
a
fast
GrzB-mediated
their
first
killing
events
to
slow
receptor–mediated
during
subsequent
encounters.
Target
reduced
intracellular
perforin
increased
surface-CD95L
over
time,
showing
how
cytotoxicity
is
controlled.
Without
perforin,
were
unable
perform
serial
only
killed
once
via
receptors.
In
contrast,
absence
CD95
on
targets
did
not
impair
killing.
This
demonstrates
are
differentially
regulated
Journal of Clinical Medicine,
Journal Year:
2019,
Volume and Issue:
8(7), P. 1025 - 1025
Published: July 12, 2019
Mesenchymal
stromal/stem
cells
(MSCs)
exist
in
almost
all
tissues,
possessing
the
potential
to
differentiate
into
specialized
cell
types
and
exert
immunomodulatory
functions.
Thus,
they
have
attracted
much
attention
as
a
promising
therapeutic
candidate.
Recent
studies
demonstrated
that
paracrine
signaling
is
mainly
responsible
for
involvement
of
MSCs
modulation
immune
responses
progression
diseases.
Through
release
secretome
consisting
diverse
range
cytokines,
chemokines,
extracellular
vesicles
(EVs),
convey
regulatory
messages
recipient
microenvironment.
In
this
review,
we
focus
on
recent
advances
how
contribute
immunomodulation
through
secretion
factors.
The
further
improved
understanding
molecular
mechanism
underlying
interactions
between
highlights
biology
microenvironment
promotes
clinical
application
regenerative
medicine